APA

Simões A. E. S., Pereira D. M., Gomes S. E., Brito H., Carvalho T., French A., Castro R. E., Steer C. J., Thibodeau S. N., Rodrigues C. M. P. & Borralho P. M. (20160929). Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. : Cell death & disease.

Chicago

Simões A E S, Pereira D M, Gomes S E, Brito H, Carvalho T, French A, Castro R E, Steer C J, Thibodeau S N, Rodrigues C M P and Borralho P M. 20160929. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. : Cell death & disease.

Harvard

Simões A. E. S., Pereira D. M., Gomes S. E., Brito H., Carvalho T., French A., Castro R. E., Steer C. J., Thibodeau S. N., Rodrigues C. M. P. and Borralho P. M. (20160929). Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. : Cell death & disease.

MLA

Simões A E S, Pereira D M, Gomes S E, Brito H, Carvalho T, French A, Castro R E, Steer C J, Thibodeau S N, Rodrigues C M P and Borralho P M. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. : Cell death & disease. 20160929.